Dong-A University Hospital

South Korea

Country: South Korea

Ownership: Private

Established: 1990-01-01

Employees: -

Market Cap: -

Website: http://www.damc.or.kr/eng/

Clinical Trials

Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)

Phase 2

Completed

Conditions: B-cell Lymphomas

Interventions: Drug: Oxaliplatin, Prednisolone

First Posted Date: 2010-02-12

Last Posted Date: 2014-11-04

Lead Sponsor: Dong-A University Hospital

Target Recruit Count: 42

Registration Number: NCT01068392

Locations: 🇰🇷
Dong-A University Hospital, Busan, Korea, Republic of

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy